ACUTE ISCHAEMIC STROKE
Condition Identity
Acute Ischaemic Stroke
Acute neurological emergency
Large vessel occlusion (LVO) vs Small vessel (lacunar) vs Cardioembolic vs Cryptogenic vs Other determined aetiology
TOAST classification used for aetiology. Haemorrhagic stroke excluded by CT before thrombolysis
Epidemiology
Risk Factors
- Hypertension (single most important modifiable risk factor)
- Atrial fibrillation (causes 15โ20% of ischaemic strokes)
- Diabetes mellitus
- Dyslipidaemia
- Smoking
- Carotid artery disease
- Prior stroke or TIA
- Heart failure and cardiomyopathy
- Patent foramen ovale (cryptogenic stroke)
- Obstructive sleep apnoea
- Obesity
- Physical inactivity
- Excessive alcohol use
- Hypercoagulable states (antiphospholipid syndrome, thrombophilia)
- Oral contraceptive pill (especially with migraine with aura)
- Age, male sex, and non-White ethnicity
- Socioeconomic deprivation
Signs & Symptoms
- FAST signs: Face asymmetry, Arm drift, Speech disturbance (screening tool)
- Hemiplegia or hemiparesis (upper motor neuron pattern)
- Hemisensory loss
- Gaze deviation towards the lesion (frontal lobe lesion)
- Neglect (non-dominant parietal lobe)
- Homonymous hemianopia
- Aphasia (dominant hemisphere)
- Upgoing plantar response (Babinski sign)
- National Institutes of Health Stroke Scale (NIHSS) used to quantify severity
- Atrial fibrillation on pulse palpation or cardiac monitoring
- Sudden-onset facial droop or asymmetry (unilateral)
- Arm or leg weakness: unilateral hemiparesis or hemiplegia
- Speech disturbance: dysarthria (slurred speech) or dysphasia (difficulty finding/producing words)
- Sudden visual loss or visual field defect (homonymous hemianopia)
- Diplopia or gaze deviation
- Ataxia, loss of coordination, unsteady gait
- Sudden severe headache (more characteristic of haemorrhagic stroke)
- Vertigo (posterior circulation)
- Dysphagia (difficulty swallowing)
- Sudden confusion
Complications
DOWNSTREAM CLINICAL COMPLICATIONS & SEQUELAE
- Cerebral oedema and herniation (malignant MCA infarction)
- Haemorrhagic transformation of infarct
- Aspiration pneumonia (dysphagia)
- Deep vein thrombosis and pulmonary embolism (immobility)
- Urinary tract infection
- Pressure sores
- Post-stroke epilepsy (5โ10%)
- Post-stroke depression (30โ40%)
- Vascular dementia
- Falls and fractures
- Spasticity and contractures
- Central post-stroke pain
- Recurrent stroke (10โ15% in first year)
Diagnostic Criteria
DIAGNOSTIC RED FLAGS & EMERGENCY RULE-OUTS
- Sudden-onset severe headache ('worst of my life') โ raises suspicion for haemorrhagic stroke or subarachnoid haemorrhage
- Rapidly declining consciousness or GCS
- Signs of raised intracranial pressure (papilloedema, Cushing triad)
- Seizures at onset (more haemorrhagic or metabolic)
- NIHSS >25: severe stroke, high risk of herniation
- Sudden bilateral blindness or brainstem signs (posterior circulation)
- Sudden focal neurological deficit consistent with vascular territory
- Symptoms present for >24 hours distinguishes stroke from TIA (although DWI-positive lesions may occur in TIA)
- NIHSS score quantifies deficit severity: 0 = normal; 1โ4 = minor; 5โ15 = moderate; 16โ20 = moderate-severe; 21โ42 = severe
| Condition | Distinguishing Features | Recommended Workup |
|---|---|---|
| Hypoglycaemia (must be excluded immediately with bedside glucose) | โ | โ |
| Todd paralysis (post-ictal focal weakness) | โ | โ |
| Hypertensive encephalopathy | โ | โ |
| Brain tumour with acute bleeding | โ | โ |
| Complicated migraine (hemiplegic migraine) | โ | โ |
| Subdural haematoma | โ | โ |
| Brain abscess | โ | โ |
| Multiple sclerosis relapse | โ | โ |
| Functional neurological disorder | โ | โ |
Investigations
Bedside Tests
- Bedside capillary glucose (exclude hypoglycaemia immediately)
- 12-lead ECG (atrial fibrillation detection)
- Oxygen saturation
- Blood pressure (both arms)
- NIHSS assessment by trained clinician
- Swallow screen before oral intake
First-Line Diagnostic Tests
- Non-contrast CT head: immediately to exclude haemorrhage (required before thrombolysis)
- CT angiography (CTA) of intracranial and neck vessels: if LVO suspected
- Full blood count
- INR and APTT (before thrombolysis)
- Blood glucose
- Urea and electrolytes
- Troponin (concurrent cardiac event)
- Lipid profile
- HbA1c
Confirmatory & Specialized Tests
- MRI head (DWI sequence): more sensitive for early ischaemia; posterior fossa lesions
- MR angiography: vessel imaging without contrast
- Carotid Doppler ultrasound: if anterior circulation stroke (carotid stenosis)
- Echocardiography (transthoracic and transoesophageal): cardioembolic source
- 24-hour cardiac monitoring / 7-day Holter: paroxysmal AF
- Thrombophilia screen (in young stroke)
- Antiphospholipid antibodies
- Fasting glucose, HbA1c
- Prolonged cardiac loop recorder (3 years): cryptogenic stroke
Continuous & Serial Monitoring
- Continuous cardiac monitoring for 72 hours (paroxysmal AF)
- Blood glucose 4โ6 hourly (target 4โ11 mmol/L)
- Blood pressure monitoring (do not lower acutely unless >185/110 before thrombolysis)
- Temperature (fever worsens outcomes)
- Swallow assessment within 4 hours (SLT)
- Neurological observations every 15โ60 minutes post-thrombolysis
Nonpharmacological Management
- Stroke unit admission (reduces mortality and dependency by 20% vs general ward)
- Nil by mouth until formal swallow assessment
- Nasogastric tube feeding if unsafe swallow
- Supplemental oxygen only if SpOโ <94%
- Maintain normoglycaemia (treat if >11 mmol/L)
- Treat fever with paracetamol (target normothermia)
- Pressure ulcer prevention: regular repositioning, pressure-relieving mattress
- VTE prophylaxis: anti-embolism stockings and LMWH (after haemorrhage excluded)
- Early physiotherapy, occupational therapy, and speech and language therapy (SLT)
- Psychological support and post-stroke depression screening
- Cardiac rehabilitation and secondary prevention programme
Monitoring
- NIHSS improvement of โฅ4 points or return to 0 (meaningful recovery)
- Absence of symptomatic intracranial haemorrhage post-thrombolysis (<2% with alteplase)
- Haemodynamic and glycaemic stability
- Successful recanalisation on post-thrombectomy angiography (TICI 2bโ3)
- Blood glucose every 4โ6 hours in acute phase
- Serial FBC and coagulation if on anticoagulation or thrombolysis
- Renal function and LFTs at 1 month if new medications initiated
- LDL at 6 weeks post-stroke (target <1.4 mmol/L ESC high-risk)
- Clinical neurology review at 1 month post-discharge
- Brain imaging at 24 hours post-thrombolysis
- Cardiac monitoring report at 4 weeks
- Echocardiography report at 4 weeks
- Carotid intervention within 2 weeks if stenosis โฅ50%
- Ongoing stroke rehabilitation: 6 months to 2 years for neurological recovery
- Neurological deterioration post-thrombolysis: urgent repeat CT to exclude haemorrhage
- Malignant MCA infarction: decompressive hemicraniectomy within 48 hours
- Hydrocephalus from cerebellar infarction: neurosurgical consultation
- Post-stroke seizures: initiate antiepileptic therapy
- Aspiration pneumonia: antibiotic therapy, dietitian review
- Maximum spontaneous neurological recovery occurs within 3โ6 months
- Continued improvement may occur up to 2 years post-stroke through neuroplasticity and rehabilitation
Prevention
- Anticoagulation for AF (reduces stroke risk by 68%)
- Carotid endarterectomy for symptomatic stenosis โฅ70%
- PFO closure considered in cryptogenic stroke <60 years
- Blood pressure control (target <130/80 mmHg)
- Antiplatelet or anticoagulant therapy
- Statin therapy
- Atrial fibrillation detection and anticoagulation
- Diabetes management
- Smoking cessation
- Physical activity
- Mediterranean diet
- FAST recognition and emergency call (999/112 immediately)
- Medication adherence (antiplatelet, statin, antihypertensive)
- Lifestyle modifications
- Risk of recurrence and warning signs of TIA
- Driving restrictions (minimum 1 month for TIA; variable for stroke)
- When to seek emergency care
EMERGENCY RETURN PRECAUTIONS
- Sudden new weakness, numbness, or facial drooping
- Speech difficulty or confusion
- Sudden severe headache
- Sudden vision loss
- Unsteadiness or falls
Prognosis
Stroke outcomes vary widely by severity, territory, and time to treatment. Approximately 10โ15% of patients die within 30 days. Of survivors: 25โ35% have significant long-term disability (mRS 3โ5); 40โ50% have good functional recovery (mRS 0โ2). Thrombolysis reduces disability by approximately 30%. Mechanical thrombectomy in LVO significantly improves functional outcomes (absolute risk reduction 19% mRS 0โ2 vs control in DAWN trial). Recurrent stroke risk is 10โ15% at 1 year without secondary prevention.
Referral Criteria
ICU & EMERGENCY RESUSCITATION INDICATIONS
- Malignant MCA infarction with declining consciousness
- Posterior fossa stroke with cerebellar oedema and hydrocephalus
- Haemodynamic instability post-thrombolysis
- Symptomatic haemorrhagic transformation
- Status epilepticus post-stroke
HOSPITAL ADMISSION INDICATIONS
- All strokes: urgent admission to stroke unit
- TIA with ABCD2 โฅ4 or crescendo TIA: emergency admission
- Neurology / Stroke team: immediate on admission
- Neuroradiology: CTPA/MRI interpretation
- Interventional neuroradiology: mechanical thrombectomy
- Cardiology: cardiac source of embolism, AF management
- Vascular surgery: carotid endarterectomy
- Neurosurgery: malignant MCA infarction, cerebellar infarction with oedema
- Rehabilitation team: physiotherapy, OT, SLT, neuropsychology
All content in Medobo is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional and local institutional protocols before administering medication or initiating treatment.